Considerations in Sequencing BCMA-Targeting Bispecifics and CAR-T Therapies in R/R MM

Opinion
Video

Myeloma specialists discuss considerations they consider when determining how they sequence CAR T-cell therapies and bispecific antibodies.

Recent Videos
5 experts in this video
4 experts in this video
5 experts in this video
4 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content